• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NTI 1.39% 7.1¢

NEUROTECH INTERNATIONAL LIMITED - Announcements

Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical... Neurotech International Limited is an Australia-based clinical-stage biopharmaceutical development company. The Company is focused predominately on pediatric neurological disorders with a broad-spectrum oral cannabinoid drug therapy called NTI164. It has completed a Phase II/III randomized, double-blind, placebo-controlled clinical trial in autism spectrum disorder (ASD) with clinically significant benefits reported across a number of clinically validated measures and safety. In addition, it has completed and reported significant and clinically meaningful Phase I/II trials in ASD and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS), collectively PANDAS/PANS along with Rett Syndrome. NTI164 is being developed as a therapeutic drug product for a range of neurological disorders in children where neuroinflammation is involved.More

Announcements


NTI Notice of Meeting - Despatch23/10/17 download Created with Sketch. 1.56MB
NTI Reinstatement to Official QuotationPRICE SENSITIVE16/10/17 download Created with Sketch. 251.67KB
NTI Capital Raising CompletedPRICE SENSITIVE16/10/17 download Created with Sketch. 595.56KB
NTI Suspension from Official QuotationPRICE SENSITIVE12/10/17 download Created with Sketch. 559.91KB
NTI Trading HaltPRICE SENSITIVE11/10/17 download Created with Sketch. 764.02KB
NTI Neurotech Investor Presentation04/10/17 download Created with Sketch. 3.03MB
NTI Response to ASX QueryPRICE SENSITIVE03/10/17 download Created with Sketch. 916.91KB
NTI Neurotech Presentations28/09/17 download Created with Sketch. 596.79KB
NTI Clinical Trial Preliminary OutcomesPRICE SENSITIVE27/09/17 download Created with Sketch. 619.33KB
NTI Trading HaltPRICE SENSITIVE25/09/17 download Created with Sketch. 531.65KB
NTI Distributor UpdatePRICE SENSITIVE14/09/17 download Created with Sketch. 604.91KB
NTI Corporate Governance Statement06/09/17 download Created with Sketch. 379.16KB
NTI Appendix 4EPRICE SENSITIVE01/09/17 download Created with Sketch. 365.03KB
NTI Annual Report to shareholders31/08/17 download Created with Sketch. 955.11KB
NTI Appendix 4G31/08/17 download Created with Sketch. 378.22KB
NTI Italian Distributor UpdatePRICE SENSITIVE21/08/17 download Created with Sketch. 476.74KB
NTI Quarterly Report and Appendix 4CPRICE SENSITIVE31/07/17 download Created with Sketch. 794.83KB
NTI Neurotech completes Turkey shipmentPRICE SENSITIVE10/07/17 download Created with Sketch. 638.08KB
NTI Neurotech renews Turkey distribution agreementPRICE SENSITIVE26/06/17
NTI Distribution UpdatePRICE SENSITIVE19/06/17 download Created with Sketch. 498.83KB
NTI 2017 European Neuro Convention Presentation08/06/17 download Created with Sketch. 2.61MB
NTI Mente Autism UpdatePRICE SENSITIVE05/06/17 download Created with Sketch. 600.32KB
NTI US Clinical Trial UpdatePRICE SENSITIVE29/05/17 download Created with Sketch. 591.33KB
NTI First Shipment to GreecePRICE SENSITIVE25/05/17 download Created with Sketch. 600.17KB
NTI Distribution UpdatePRICE SENSITIVE22/05/17 download Created with Sketch. 583.41KB
NTI Appendix 3B and Release of Restricted Securities from Escrow15/05/17 download Created with Sketch. 268.43KB
NTI FDA UpdatePRICE SENSITIVE12/05/17 download Created with Sketch. 475.69KB
NTI Quarterly ReportsPRICE SENSITIVE26/04/17 download Created with Sketch. 2.78MB
NTI Distribution Partner UpdatePRICE SENSITIVE26/04/17 download Created with Sketch. 477.23KB
NTI Release of 699,000 Shares from Escrow21/04/17 download Created with Sketch. 342.03KB
NTI FDA Pre submission and World Autism Awareness DayPRICE SENSITIVE30/03/17 download Created with Sketch. 490.57KB
NTI US Clinical Trial UpdatePRICE SENSITIVE29/03/17 download Created with Sketch. 483KB
NTI Mente Pro UpdatePRICE SENSITIVE09/03/17 download Created with Sketch. 597.39KB
NTI Austrian Distribution PartnerPRICE SENSITIVE02/03/17 download Created with Sketch. 480.5KB
NTI Half Year Report and AccountsPRICE SENSITIVE01/03/17 download Created with Sketch. 1.2MB
NTI Emergo Appointment06/02/17 download Created with Sketch. 499.48KB
NTI Appendix 4C - quarterlyPRICE SENSITIVE31/01/17 download Created with Sketch. 281.51KB
NTI Company Update31/01/17 download Created with Sketch. 531.39KB
NTI Mente Autism ShipmentPRICE SENSITIVE22/12/16 download Created with Sketch. 488.44KB
NTI Scientific Advisory Board20/12/16 download Created with Sketch. 523.21KB
NTI AGM Results29/11/16 download Created with Sketch. 211.62KB
NTI Investor Presentation28/11/16 download Created with Sketch. 2.79MB
NTI Notice of Meeting15/11/16 download Created with Sketch. 440.2KB
NTI Launch of Mente AutismPRICE SENSITIVE11/11/16 download Created with Sketch. 289.14KB
NTI Neurotech Commences Trade on ASX04/11/16 download Created with Sketch. 367.53KB
NTI Becoming a substantial holder04/11/16 download Created with Sketch. 56.25KB
NTI Becoming a substantial holder04/11/16 download Created with Sketch. 787.69KB
NTI Initial Director's Interest Notice04/11/16 download Created with Sketch. 336.54KB
NTI Initial Director's Interest Notice04/11/16 download Created with Sketch. 229.68KB
NTI Initial Director's Interest Notice04/11/16 download Created with Sketch. 234.18KB
NTI Initial Director's Interest Notice04/11/16 download Created with Sketch. 227.87KB
NTI Initial Director's Interest Notice04/11/16 download Created with Sketch. 222.38KB
NTI Initial Director's Interest Notice04/11/16 download Created with Sketch. 222.07KB
NTI Becoming a substantial holder04/11/16 download Created with Sketch. 72.42KB
NTI Additional Confirmation Statements03/11/16 download Created with Sketch. 292.03KB
NTI Terms of Options03/11/16 download Created with Sketch. 69.62KB
NTI Restricted Securities Statement03/11/16 download Created with Sketch. 208.84KB
NTI Security Trading Policy03/11/16 download Created with Sketch. 103.15KB
NTI Financial Accounts03/11/16 download Created with Sketch. 13.61MB
NTI Constitution03/11/16 download Created with Sketch. 3.02MB
NTI Prospectus03/11/16 download Created with Sketch. 4.19MB
NTI Top 20 holders03/11/16 download Created with Sketch. 52.18KB
NTI Distribution Schedule03/11/16 download Created with Sketch. 86.85KB
NTI Appendix 1A and Information Form and Checklist03/11/16 download Created with Sketch. 318.82KB
NTI Pre-Quotation Disclosure03/11/16 download Created with Sketch. 91.32KB
NTI ASX Notice03/11/16 download Created with Sketch. 90.37KB
NTI Admission to Official ListPRICE SENSITIVE03/11/16 download Created with Sketch. 80.8KB
NTI Notice of Meeting - Despatch
23/10/17 download Created with Sketch. 1.56MB
NTI Reinstatement to Official Quotation
16/10/17PRICE SENSITIVE download Created with Sketch. 251.67KB
NTI Capital Raising Completed
16/10/17PRICE SENSITIVE download Created with Sketch. 595.56KB
NTI Suspension from Official Quotation
12/10/17PRICE SENSITIVE download Created with Sketch. 559.91KB
NTI Trading Halt
11/10/17PRICE SENSITIVE download Created with Sketch. 764.02KB
NTI Neurotech Investor Presentation
04/10/17 download Created with Sketch. 3.03MB
NTI Response to ASX Query
03/10/17PRICE SENSITIVE download Created with Sketch. 916.91KB
NTI Neurotech Presentations
28/09/17 download Created with Sketch. 596.79KB
NTI Clinical Trial Preliminary Outcomes
27/09/17PRICE SENSITIVE download Created with Sketch. 619.33KB
NTI Trading Halt
25/09/17PRICE SENSITIVE download Created with Sketch. 531.65KB
NTI Distributor Update
14/09/17PRICE SENSITIVE download Created with Sketch. 604.91KB
NTI Corporate Governance Statement
06/09/17 download Created with Sketch. 379.16KB
NTI Appendix 4E
01/09/17PRICE SENSITIVE download Created with Sketch. 365.03KB
NTI Annual Report to shareholders
31/08/17 download Created with Sketch. 955.11KB
NTI Appendix 4G
31/08/17 download Created with Sketch. 378.22KB
NTI Italian Distributor Update
21/08/17PRICE SENSITIVE download Created with Sketch. 476.74KB
NTI Quarterly Report and Appendix 4C
31/07/17PRICE SENSITIVE download Created with Sketch. 794.83KB
NTI Neurotech completes Turkey shipment
10/07/17PRICE SENSITIVE download Created with Sketch. 638.08KB
NTI Neurotech renews Turkey distribution agreement
26/06/17PRICE SENSITIVE
NTI Distribution Update
19/06/17PRICE SENSITIVE download Created with Sketch. 498.83KB
NTI 2017 European Neuro Convention Presentation
08/06/17 download Created with Sketch. 2.61MB
NTI Mente Autism Update
05/06/17PRICE SENSITIVE download Created with Sketch. 600.32KB
NTI US Clinical Trial Update
29/05/17PRICE SENSITIVE download Created with Sketch. 591.33KB
NTI First Shipment to Greece
25/05/17PRICE SENSITIVE download Created with Sketch. 600.17KB
NTI Distribution Update
22/05/17PRICE SENSITIVE download Created with Sketch. 583.41KB
NTI Appendix 3B and Release of Restricted Securities from Escrow
15/05/17 download Created with Sketch. 268.43KB
NTI FDA Update
12/05/17PRICE SENSITIVE download Created with Sketch. 475.69KB
NTI Quarterly Reports
26/04/17PRICE SENSITIVE download Created with Sketch. 2.78MB
NTI Distribution Partner Update
26/04/17PRICE SENSITIVE download Created with Sketch. 477.23KB
NTI Release of 699,000 Shares from Escrow
21/04/17 download Created with Sketch. 342.03KB
NTI FDA Pre submission and World Autism Awareness Day
30/03/17PRICE SENSITIVE download Created with Sketch. 490.57KB
NTI US Clinical Trial Update
29/03/17PRICE SENSITIVE download Created with Sketch. 483KB
NTI Mente Pro Update
09/03/17PRICE SENSITIVE download Created with Sketch. 597.39KB
NTI Austrian Distribution Partner
02/03/17PRICE SENSITIVE download Created with Sketch. 480.5KB
NTI Half Year Report and Accounts
01/03/17PRICE SENSITIVE download Created with Sketch. 1.2MB
NTI Emergo Appointment
06/02/17 download Created with Sketch. 499.48KB
NTI Appendix 4C - quarterly
31/01/17PRICE SENSITIVE download Created with Sketch. 281.51KB
NTI Company Update
31/01/17 download Created with Sketch. 531.39KB
NTI Mente Autism Shipment
22/12/16PRICE SENSITIVE download Created with Sketch. 488.44KB
NTI Scientific Advisory Board
20/12/16 download Created with Sketch. 523.21KB
NTI AGM Results
29/11/16 download Created with Sketch. 211.62KB
NTI Investor Presentation
28/11/16 download Created with Sketch. 2.79MB
NTI Notice of Meeting
15/11/16 download Created with Sketch. 440.2KB
NTI Launch of Mente Autism
11/11/16PRICE SENSITIVE download Created with Sketch. 289.14KB
NTI Neurotech Commences Trade on ASX
04/11/16 download Created with Sketch. 367.53KB
NTI Becoming a substantial holder
04/11/16 download Created with Sketch. 56.25KB
NTI Becoming a substantial holder
04/11/16 download Created with Sketch. 787.69KB
NTI Initial Director's Interest Notice
04/11/16 download Created with Sketch. 336.54KB
NTI Initial Director's Interest Notice
04/11/16 download Created with Sketch. 229.68KB
NTI Initial Director's Interest Notice
04/11/16 download Created with Sketch. 234.18KB
NTI Initial Director's Interest Notice
04/11/16 download Created with Sketch. 227.87KB
NTI Initial Director's Interest Notice
04/11/16 download Created with Sketch. 222.38KB
NTI Initial Director's Interest Notice
04/11/16 download Created with Sketch. 222.07KB
NTI Becoming a substantial holder
04/11/16 download Created with Sketch. 72.42KB
NTI Additional Confirmation Statements
03/11/16 download Created with Sketch. 292.03KB
NTI Terms of Options
03/11/16 download Created with Sketch. 69.62KB
NTI Restricted Securities Statement
03/11/16 download Created with Sketch. 208.84KB
NTI Security Trading Policy
03/11/16 download Created with Sketch. 103.15KB
NTI Financial Accounts
03/11/16 download Created with Sketch. 13.61MB
NTI Constitution
03/11/16 download Created with Sketch. 3.02MB
NTI Prospectus
03/11/16 download Created with Sketch. 4.19MB
NTI Top 20 holders
03/11/16 download Created with Sketch. 52.18KB
NTI Distribution Schedule
03/11/16 download Created with Sketch. 86.85KB
NTI Appendix 1A and Information Form and Checklist
03/11/16 download Created with Sketch. 318.82KB
NTI Pre-Quotation Disclosure
03/11/16 download Created with Sketch. 91.32KB
NTI ASX Notice
03/11/16 download Created with Sketch. 90.37KB
NTI Admission to Official List
03/11/16PRICE SENSITIVE download Created with Sketch. 80.8KB
(20min delay)
Last
7.1¢
Change
-0.001(1.39%)
Mkt cap ! $72.23M
Open High Low Value Volume
7.2¢ 7.2¢ 7.1¢ $270.0K 3.761M

Buyers (Bids)

No. Vol. Price($)
1 17129 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
7.3¢ 176986 2
View Market Depth
Last trade - 15.35pm 23/08/2024 (20 minute delay) ?
Last
7.2¢
  Change
-0.001 ( 0.69 %)
Open High Low Volume
7.2¢ 7.2¢ 7.1¢ 158734
Last updated 15.34pm 23/08/2024 ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.